All articles by

FDA approves Celltrion’s Eydenzelt for eye diseases

Celltrion has received approval from the US Food and Drug Administration (FDA) for the biosimilar product, Eydenzelt (aflibercept-boav), to treat…
Turbine and AstraZeneca partner for ADC discovery

Turbine and AstraZeneca have entered a partnership to enhance the discovery of antibody-drug conjugates (ADCs) using the former’s virtual disease…
Synaffix and Qurient enter licensing deal for dual-payload ADC

Synaffix, a company of Swiss drugmaker Lonza, has entered into a licensing agreement with South Korean biopharmaceutical firm Qurient to…
FDA approves Lilly’s Inluriyo to treat advanced breast cancer

Eli Lilly and Company (Lilly) has received approval from the US Food and Drug Administration (FDA) for Inluriyo (imlunestrant 200mg…
Moderna opens UK vaccine manufacturing facility

Moderna has opened the Moderna Innovation and Technology Centre (MITC), its new vaccine manufacturing and research and development (R&D) facility…

Sanofi announces $625m to venture capital arm

Sanofi has committed an additional $625m to its venture capital arm, Sanofi Ventures, bringing its total assets under management to…
FDA to priority-review Daiichi Sankyo and AZ’s Enhertu sBLA

Daiichi Sankyo and AstraZeneca have received priority review from the US Food and Drug Administration (FDA) for the supplemental biologics…
TegMine and Boehringer Ingelheim partner on cancer therapeutics

TegMine Therapeutics has announced a collaboration with Boehringer Ingelheim to advance a new two-factor antibody system, aimed at developing antibody-drug…
Merck and Siemens extend digital transformation partnership in life sciences

Merck and Siemens have signed a memorandum of understanding (MoU) to enhance their strategic partnership, aimed at accelerating digital transformation…
Ionis and Sobi’s Tryngolza gains approval in EU for FCS treatment

Ionis Pharmaceuticals and Sobi have announced the approval of Tryngolza (olezarsen) in the European Union (EU) for adults with familial…